Ability of teicoplanin and vancomycin to induce contraction of, and histamine release from, pulmonary tissue of humans, monkeys and guinea pigs

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 2, 1999, Pages 233-242

  Nabe, Takeshi ^a   Yamamura, Hideki ^a   Hatanaka, Masakazu ^a   Shinoda, Naoki ^a   Shimizu, Kaname ^a   Mizutani, Nobuaki ^a   Yamashita, Kazunori ^a   Horiba, Michiaki ^b   Kohno, Shigekatsu ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HISTAMINE; TEICOPLANIN; VANCOMYCIN;

AIRWAY; ANIMAL TISSUE; ARTICLE; BONE MARROW; BRONCHOSPASM; BRONCHUS; BRONCHUS TONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GUINEA PIG; HISTAMINE RELEASE; HUMAN; HUMAN TISSUE; LEUKOCYTE; LUNG PARENCHYMA; MALE; MAST CELL; MONKEY; NONHUMAN; RISK; SMOOTH MUSCLE CONTRACTION; TRACHEA;

ANIMALS; ANTI-BACTERIAL AGENTS; BONE MARROW CELLS; BRONCHI; CELLS, CULTURED; FEMALE; GUINEA PIGS; HISTAMINE; HUMANS; LEUKOCYTES; LUNG; MACACA; MALE; MICE; MICE, INBRED BALB C; TEICOPLANIN; TRACHEA; VANCOMYCIN;

EID: 0033000518     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.2.233     Document Type: Article

References (43)

1. Williams, A. H. & Gruneberg, R. N. (1984). Teicoplanin. Journal of Antimicrobial Chemotherapy 14, 441-5.
2. Williams, A. H. & Gruneberg, R. N. (1988). Teicoplanin revisited. Journal of Antimicrobial Chemotherapy 24, 397-401.
3. Lagast, H., Dodion, P. & Klastersky, J. (1986). Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin. Journal of Antimicrobial Chemotherapy 18, 513-20.
4. Glupczynski, Y., Lagast, H., Van der Auwera, P., Thys, J. P., Crokaert, F., Yourassowsky, E. et al. (1986). Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria. Antimicrobial Agents and Chemotherapy 29, 52-7.
5. Garrelts, J. C. & Peterie, J. D. (1985). Vancomycin and the 'red man's syndrome'. New England Journal of Medicine 312, 245.
6. Newfield, P. & Roizen, M. F. (1979). Hazards of rapid administration of vancomycin. Annals of Internal Medicine 91, 581.
7. Odio, C., Mohs, E., Sklar, F. H., Nelson, J. D. & McCracken, G. H. (1984). Adverse reactions to vancomycin used as prophylaxis for CSF shunt procedures. American Journal of Diseases of Children 138, 17-9.
8. Dajee, H., Laks, H., Miller, J. & Oren, R. (1984). Profound hypotension from rapid vancomycin administration during cardiac operation. Journal of Thoracic and Cardiovascular Surgery 87, 145-6.
9. Pau, A. K. & Khakoo, R. (1985). 'Red-neck syndrome' with slow infusion of vancomycin. New England Journal of Medicine 313, 756-7.
10. Davis, R. L., Smith, A. L. & Koup, J. R. (1986). The 'red man's syndrome' and slow infusion of vancomycin. Annals of Internal Medicine 104, 285-6.
11. Southorn, P. A., Plevak, D. J., Wright, A. J. & Wilson, W. R. (1986). Adverse effects of vancomycin administered in the perioperative period. Mayo Clinic Proceedings 61, 721-4.
12. Polk, R. E., Healy, D. P., Schwartz, L. B., Rock, D. T., Garson, M. L. & Roller, K. (1988). Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. Journal of Infectious Diseases 157, 502-7.
13. Healy, D. P., Sahai, J. V., Fuller, S. H. & Polk, R. E. (1990). Vancomycin-induced histamine release and 'red man syndrome': comparison of 1- and 2-hour infusions. Antimicrobial Agents and Chemotherapy 34, 550-4.
14. Sahai, J., Healy, D. P., Shelton, M. J., Miller, J. S., Ruberg, S. J. & Polk, R. (1990). Comparison of vancomycin- and teicoplanin-induced histamine release and 'red man syndrome'. Antimicrobial Agents and Chemotherapy 34, 765-9.
15. Kelly, H. W. & Lovato, C. (1984). Antibiotic use in cystic fibrosis. Drug Intelligence and Clinical Pharmacy 18, 772-83.
16. Weathers, L., Riggs, D., Santeiro, M. & Weibley, R. E. (1990). Aerosolized vancomycin for treatment of airway colonization by methicillin-resistant Staphylococcus aureus. Pediatric Infectious Disease Journals, 220-1.
17. Miller, W. F. (1973). Aerosol therapy in acute and chronic respiratory disease. Archives of Internal Medicine 131, 148-55.
18. Wanner, A. & Rao, A. (1980). Clinical indications for and effects of bland, mucolytic and antimicrobial aerosols. American Review of Respiratory Disease 122, 79-87.
19. Levine, B. B. & Redmond, A. P. (1968). The nature of the antigen-antibody complexes initiating the specific wheal-and-flare reaction in sensitized man. Journal of Clinical Investigation 47, 556-67.
20. Tada, T. & Okumura, K. (1971). Regulation of homocytotropic antibody formation in the rat. I. Feed-back regulation by passively administered antibody. Journal of Immunology 106, 1002-11.
21. Levine, B. B., Chang, H. & Vaz, N. M. (1971). The production of hapten-specific reaginic antibodies in the guinea pig. Journal of Immunology 106, 29-33.
22. Watanabe-Kohno, S., Yamamura, H., Nabe, T., Horiba, M. & Ohata, K. (1992). MCI-826 is a potent and selective antagonist of peptide leukotrienes (p-LTs) and has characteristics distinctive from those of FPL 55712. Japanese Journal of Pharmacology 60, 1-8.
23. Watanabe-Kohno, S., Yasui, K., Nabe, T., Yamamura, H., Horiba, M. & Ohata, K. (1992). Significant role of peptide leukotrienes (p-LTs) in the antigen-induced contractions of human and guinea pig lung parenchymas and bronchi or tracheas in vitro. Japanese Journal of Pharmacology 60, 209-16.
24. Yamamura, H., Taira, M., Negi, H., Nanbu, F., Kohno, S. W. & Ohata, K. (1988). Effect of AA-861, a selective 5-lipoxygenase inhibitor, on models of allergy in several species. Japanese Journal of Pharmacology 47, 261-71.
25. Watanabe-Kohno, S., Shimizu, T., Mizuta, J., Ogino, K., Yamamura, H. & Ohata, K. (1990). Effect of procaterol on the isolated airway smooth muscle and the release of anaphylactic chemical mediators from the isolated lung fragments. Arzneimittel-Forschung 40, 669-74.
26. Nakano, T., Sonoda, T., Hayashi, A., Yamatodani, Y., Kanayama, Y., Yamamura, T. et al. (1985). Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. Journal of Experimental Medicine 162, 1025-43.
27. 4 from bone marrow-derived mast cells. European Journal of Pharmacology 257, 235-42.
28. Itoh, Y., Oishi, R., Nishibori, M. & Saeki, K. (1989). Histamine turnover in the rat hypothalamic nuclei estimated from α-fluoromethylhistidine-induced histamine decrease. Japanese Journal of Pharmacology 51, 581-4.
29. Yamatodani, A., Fukuda, H., Wada, H., Iwaeda, T. & Watanabe, T. (1985). High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cation-exchange chromatography coupled with post-column derivatization fluorometry. Journal of Chromatography 344, 115-23.
30. Sahai, J., Healy, D. P., Garris, R., Berry, A. & Polk, R. E. (1989). Influence of antihistamine pretreatment on vancomycin-induced redman syndrome. Journal of Infectious Diseases 160, 876-81.
31. O'Sullivan, T. L., Ruffing, M. J., Lamp, K. C., Warbasse, L H. & Rybak, M. J. (1993). Prospective evaluation of red man syndrome in patients receiving vancomycin. Journal of Infectious Diseases 168, 773-6.
32. Ruffin, R. E., Dolovich, M. B., Wolff, R. K. & Newhouse, M. T. (1978). The effects of preferential deposition of histamine in the human airway. American Review of Respiratory Disease 117, 485-92.
33. 4. European Journal of Pharmacology 125, 29-35.
34. Muccitelli, R. M., Tucker, S. S., Hay, D. W. P., Torphy, T. J. & Wasserman, M. A. (1987). Is the guinea pig trachea a good in vitro model of human large and central airways? Comparison of leukotriene-, methacholine-, histamine- and antigen-induced contractions. Journal of Pharmacology and Experimental Therapeutics 243, 467-73.
35. Dahlen, S.-E., Hedqvist, P., Hammarström, S. & Samuelsson, B. (1980). Leukotrienes are potent constrictors of human bronchi. Nature 288, 484-6.
36. Hanna, C. J., Bach, M. K., Pare, P. D. & Schellenberg, R. R. (1981). Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro. Nature 290, 343-4.
37. McKenniff, M., Rodger, I. W., Norman, P. & Gardiner, P. J. (1988). Characterisation of receptors mediating the contractile effects of prostanoids in guinea-pig and human airways. European Journal of Pharmacology 153, 149-59.
38. Coleman, R. A. & Sheldrick, R. L. (1989). Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors. British Journal of Pharmacology 96, 688-92.
39. Henry, P. J., Rigby, P. J., Self, G. J., Preuss, J. M. & Goldie, R. G. (1990). Relationship between endothelin-1 binding site densities and constrictor activities in human and animal airway smooth muscle. British Journal of Pharmacology 100, 786-92.
40. Adner, M., Cardell, L. O., Sjoberg, T., Ottosson, A. & Edvinsson, L. (1996). Contractile endothelin-B (ETB) receptors in human small bronchi. European Respiratory Journal 9, 351-5.
41. Chand, N., Dhawan, B. N., Srimal, R. C., Rahmani, N. H., Shukla, R. K. & Altura, B. M. (1980). Reactivity of trachea, bronchi, and lung strips to histamine and carbachol in rhesus monkeys. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology 49, 729-34.
42. Nagai, H., Kondo, M., Koda, A., Nakamura, S., Hashimoto, M., Yanagihara, Y. et al. (1992). Responses of isolated Japanese monkey tracheal muscle to allergic mediators. International Archives of Allergy and Immunology 98, 70-5.
43. Polk, R. E., Israel, D., Wang, J., Venitz, J., Miller, J. & Stotka, J. (1993). Vancomycin skin tests and prediction of 'red man syndrome' in healthy volunteers. Antimicrobial Agents and Chemotherapy 37, 2139-43.